Targeting of NMDA Receptors in the Treatment of Major Depression

E-ISSN： 1873-4286|20|32|5151-5159

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.32, 2014-10, pp. : 5151-5159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1898-1922

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Brain Nicotinic Acetylcholine Receptors to Treat Major Depression and Co-Morbid Alcohol or Nicotine Addiction

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 5, 2015-06 ,pp. : 647-653

Bentham Science Publishers

Access to resources Recommend Favorite

Catecholaminergic Strategies for the Treatment of Major Depression

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 149-158

Bentham Science Publishers

Access to resources Recommend Favorite

Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment

By Nowak G. Yong L. Paul I.A.

European Journal of Pharmacology, Vol. 295, Iss. 1, 1996-01 ,pp. : 75-85

Elsevier

Access to resources Recommend Favorite

Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists

By Vasiliadis H.-M. Elie R. Dewar K.M.

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite